Rosuvastatin did not, however, reduce the hypercholesterolemia in the SR-B1/apoE dKO mice; instead, plasma total cholesterol levels were, unexpectedly, substantially increased by rosuvastatin treatment; however, the reasons for this effect remain unclear (Yu et al., 2018b). This evidence concerns the gene APOE and Hypercholesterolemia.